Gallacher Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$272K Sell
697
-2,063
-75% -$872K 0.15% 209
2026
Q1
$1.31M Buy
2,760
+1,305
+90% +$657K 0.5% 38
2025
Q4
$679K Sell
1,455
-53
-4% -$24.6K 0.26% 104
2025
Q3
$643K Sell
1,508
-147
-9% -$57K 0.25% 124
2025
Q2
$634K Sell
1,655
-48
-3% -$17.3K 0.29% 79
2025
Q1
$589K Buy
1,703
+24
+1% +$7.72K 0.29% 84
2024
Q4
$504K Buy
1,679
+79
+5% +$27.6K 0.25% 92
2024
Q3
$650K Sell
1,600
-409
-20% -$150K 0.3% 62
2024
Q2
$645K Sell
2,009
-197
-9% -$64K 0.34% 59
2024
Q1
$736K Sell
2,206
-47
-2% -$14.4K 0.37% 44
2023
Q4
$610K Sell
2,253
-92
-4% -$22.7K 0.34% 45
2023
Q3
$577K Buy
2,345
+24
+1% +$6.57K 0.36% 46
2023
Q2
$704K Sell
2,321
-197
-8% -$54.8K 0.41% 44
2023
Q1
$664K Sell
2,518
-37
-1% -$9.4K 0.4% 45
2022
Q4
$613K Buy
+2,555
New +$572K 0.37% 47

Other funds holding HCA

Gallacher Capital Management's HCA Position: Q2 2026 in Review

Gallacher Capital Management reduced its HCA Healthcare (HCA) stake by 75% in Q2 2026, selling an estimated $872K and leaving 697 shares worth $272K. The position accounts for 0.15% of the portfolio, ranked #209.

Gallacher Capital Management first reported a position in HCA in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.31M in Q1 2026. 295 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Gallacher Capital Management held 697 shares of HCA Healthcare worth $272K as of Q2 2026.
  • Gallacher Capital Management sold 2,063 HCA Healthcare shares in Q2 2026, an estimated $872K.
  • HCA Healthcare made up 0.15% of Gallacher Capital Management's portfolio in Q2 2026, its #209 holding.
  • Gallacher Capital Management first reported a position in HCA Healthcare in Q4 2022 and has held it in 15 quarters since.
  • Gallacher Capital Management's HCA Healthcare position peaked at $1.31M in Q1 2026.
  • 295 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Gallacher Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.